Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases

Journal of Infectious Diseases

Volumn 183, Issue 2, 2001, Pages 321-328

  Hübel, Kai ^a,b   Dale, David C ^a   Engert, Andreas ^b   Liles, W Conrad ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

BACTERIAL INFECTION; CENTRIFUGATION; DISEASE SEVERITY; DONOR; GRANULOCYTE TRANSFUSION; HUMAN; HYPOTENSION; LEUKAPHERESIS; MYCOSIS; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY DISTRESS; REVIEW; SAFETY; STIMULATION; TREATMENT PLANNING;

BACTERIAL INFECTIONS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKOCYTE TRANSFUSION; MYCOSES; NEUTROPENIA; NEUTROPHILS;

EID: 0035863363     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/317943     Document Type: Review

References (70)

1. Sepsis: The role of steroids and monoclonal antibodies in treatment
2. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2
3. Transfusion of neutrophils as prevention or treatment of infection in patients with neutropenia
4. The effect of leukocytic cream injections in the treatment of the neutropenias
5. Transfusions of separated leukocytes into irradiated dogs with aplastic marrows
6. Problems of leukocyte transfusions
7. The function and fate of transfused leukocytes from donors with chronic myelocytic leukemia in leukopenic recipients
8. Therapeutic granulocyte transfusions in 1993
9. Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia
10. In vitro function and post transfusion survival of granulocytes collected by continuous-flow centrifugation and by filtration leukapheresis
11. Complement activation and pulmonary leukostasis during nylon fiber filtration leukapheresis
12. Comparison of agents producing a neutrophilic leukocytosis in man: Hydrocortisone, prednisone, endotoxin and etiocholanolone
13. Nomenclature and biologic significance of cytokines involved in inflammation and the host immune response
14. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization
15. The structure of granulocyte colony-stimulating factor (r-hu-G-CSF) and its relationship to other growth factors
16. Granulocyte colony-stimulating factor (G-CSF) administration increases PMN CD32 (FcRII) expression and FcR-related functions
17. Respiratory burst in adherent human neutrophils: Triggering by colony-stimulating factors CSF-GM and CSF-G
18. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils
19. In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers
20. Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions
21. Granulocyte and granulocyte-macrophage colony-stimulating factors
22. Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases
23. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer
24. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy
25. Renewed interest in granulocyte transfusion therapy
26. A prospective randomized trial of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in adults
27. Current approach to the management of neutropenia
28. The effects of daily recombinant human granulocyte colony-stimulating factor administration in normal granulocyte donors undergoing leukapheresis
29. The effect of granulocyte colony-stimulating factor administration in healthy donors before bone marrow harvesting
30. Blood counts in healthy donors 1 year after the collection of granulocyte colony-stimulating factor-mobilized progenitor cells and the results of a second mobilization and collection
31. A comparative trial of granulocyte colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers
32. Neutrophil transfusions: Kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor and dexamethasone
33. Combined administration of G-CSF and dexamethasone for the mobilization of granulocytes in normal donors: Optimization of dosing
34. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor
35. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection
36. Evaluation and comparison of three mobilization methods for the collection of granulocytes
37. Leukocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
38. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation
39. Effect of leukocyte compatibility on neutrophil increment after transfusion of granulocyte colony-stimulating factor-mobilized prophylactic granulocyte transfusions and on clinical outcomes after stem cell transplantation
40. Preservation of function in granulocyte concentrates collected from donors stimulated with G-CSF/dexamethasone during storage at reduced temperature
41. Granulocyte transfusion in neutropenic patients
42. Granulocyte transfusion therapy in patients with malignancy
43. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function
44. Granulocyte collection efficiency and yield are enhanced by the use of a higher interface offset during apheresis of donors given granulocyte colony-stimulating factor
45. Regulation of apoptosis in neutrophils-Fas track to death?
46. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products
47. Functional characteristics of neutrophils collected and stored after administration of G-CSF
48. Clinical perspectives of granulocyte transfusions: Efficacy to date
49. Normal granulocyte transfusion therapy
50. Filtration leukapheresis for granulocyte transfusion therapy
51. Granulocyte transfusions: A controlled study in patients with acute nonlymphocytic leukemia
52. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia
53. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia
54. Successful granulocyte transfusion therapy for gram negative septicemia
55. Therapeutic granulocyte transfusions for documented infections: A controlled trial in ninety-five infectious granulocytopenic episodes
56. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome
57. Granulocyte transfusions: Efficacy in treating fungal infections in neutropenic patients following bone marrow transplantations
58. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: A pilot study
59. Granulocyte colony-stimulating factor-primed leukocyte transfusions in Candida tropicolis fungemia in neutropenic patients
60. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation
61. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B
62. Current status of granulocyte transfusions to treat neonatal sepsis
63. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis
64. Granulocyte transfusions
65. The pathology of transfusion-related acute lung injury
66. Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria
67. Return of granulocyte transfusions